We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Assay for Thyroid-Stimulating Hormone

By HospiMedica staff writers
Posted on 16 Jun 2006
A new immunoassay for thyroid-stimulating hormone (TSH) is designed for the diagnosis of hyperthyroidism and hypothyroidism.

The ability to achieve third-generation sensitivity is essential for most TSH assays, since it yields information that is useful to clinicians referring patients with subnormal TSH concentrations, according to Olympus Life and Material Science Europa (Hamburg, Germany), which developed the assay. More...


The clinical benchmark for TSH is not its analytic sensitivity but its functional sensitivity. Functional sensitivity for TSH is normally defined as the lowest concentration at which the interassay coefficient of variation is ? 20%. This demonstrates the ability of the assay to discriminate euthyroid levels (0.4-4.0 µlU/ml) from the very low levels (< 0.01 µlU/ml) obtained in patients with thyrotoxicosis.

Olympus has announced that the latest performance verification of the assay on the new Olympus AU3000i immunoassay system delivered excellent functional sensitivity (fourth generation: ? 20% coefficient of variation (CV) @ 0.002 µlU/ml) and analytic sensitivity (< 0.001 µlU/ml). Based on this performance, the company concludes that the AU3000i TSH assay is a very sensitive and precise method for the detection of human TSH in both serum and plasma. These results would seem to justify the new assay as being regarded as fourth generation.



Related Links:
Olympus Life and Material Science

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.